{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:25:19Z","timestamp":1793190319288,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.amjmed.2018.12.011","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T13:22:02Z","timestamp":1546521722000},"page":"437-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9596-0714","authenticated-orcid":false,"given":"Firas","family":"El Chaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana M.","family":"El Sahly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0001","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"issue":"9635","key":"10.1016\/j.amjmed.2018.12.011_bib0002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QCO.0b013e328334fec4","article-title":"Immunization for HIV-positive individuals","volume":"23","author":"Geretti","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0004","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cit937","article-title":"Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis","volume":"58","author":"Kern\u00e9is","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.amjmed.2018.12.011_bib0005","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/archinte.1995.00430140115012","article-title":"Distribution of CD4+ T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group","volume":"155","author":"Hanson","year":"1995","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0006","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0007","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiw146","article-title":"T-cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment","volume":"214","author":"Cobos Jim\u00e9nez","year":"2016","journal-title":"J Infect Dis"},{"issue":"8808","key":"10.1016\/j.amjmed.2018.12.011_bib0008","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0140-6736(92)91321-X","article-title":"HIV-1 viraemia and influenza","volume":"339","author":"Ho","year":"1992","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.amjmed.2018.12.011_bib0009","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM199605093341903","article-title":"Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1","volume":"334","author":"Stanley","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-131-6-199909210-00006","article-title":"Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial","volume":"131","author":"Tasker","year":"1999","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0011","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/infdis\/174.6.1332","article-title":"The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study","volume":"174","author":"Glesby","year":"1996","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0012","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00002030-199708000-00010","article-title":"Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients","volume":"11","author":"Fowke","year":"1997","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0013","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jmv.2085","article-title":"Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users","volume":"65","author":"Amendola","year":"2001","journal-title":"J Med Virol"},{"issue":"25-26","key":"10.1016\/j.amjmed.2018.12.011_bib0014","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/S0264-410X(03)00408-0","article-title":"Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy","volume":"21","author":"Iorio","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cit757","article-title":"Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Aberg","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0017","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/M15-3005","article-title":"Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older: United States, 2016","volume":"164","author":"Kim","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2018.12.011_bib0018","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf. Accessed December 9, 2018."},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00002030-198808000-00005","article-title":"Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS","volume":"2","author":"Selwyn","year":"1988","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7326\/0003-4819-104-1-38","article-title":"Bacterial pneumonia in patients with the acquired immunodeficiency syndrome","volume":"104","author":"Polsky","year":"1986","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.amjmed.2018.12.011_bib0021","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1001\/jama.1992.03490230080032","article-title":"Invasive Haemophilus influenzae infections in men with HIV infection","volume":"268","author":"Steinhart","year":"1992","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amjmed.2018.12.011_bib0022","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-116-10-806","article-title":"Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group","volume":"116","author":"Farley","year":"1992","journal-title":"Ann Intern Med"},{"issue":"RR-01","key":"10.1016\/j.amjmed.2018.12.011_bib0023","first-page":"1","article-title":"Prevention and control of Haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"63","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"26","key":"10.1016\/j.amjmed.2018.12.011_bib0024","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1056\/NEJM199112263252603","article-title":"Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection","volume":"325","author":"Steinhoff","year":"1991","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0025","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.amjmed.2018.12.011_bib0026","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM198406143102404","article-title":"Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine","volume":"310","author":"Peltola","year":"1984","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0027","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1203\/00006450-197303000-00001","article-title":"Quantitative measurement of \"natural\" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies","volume":"7","author":"Robbins","year":"1973","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0028","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/infdis\/171.5.1217","article-title":"Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine","volume":"171","author":"Weiss","year":"1995","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0029","first-page":"186","article-title":"[Fibroblast differentiation during collagen formation]","volume":"8","author":"Kruglikov","year":"1977","journal-title":"Ontogenez"},{"issue":"RR-7","key":"10.1016\/j.amjmed.2018.12.011_bib0030","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0031","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/424666","article-title":"Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects","volume":"39","author":"Wallace","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0032","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00002030-199706000-00007","article-title":"The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-1 infection: 1-year follow-up","volume":"11","author":"Bodsworth","year":"1997","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0033","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jmv.1890460109","article-title":"Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men","volume":"46","author":"Hess","year":"1995","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0034","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.vaccine.2005.07.102","article-title":"Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical Bayesian meta-analysis","volume":"24","author":"Shire","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0035","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/infdis\/jir180","article-title":"Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults","volume":"203","author":"Crum-Cianflone","year":"2011","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0036","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/374562","article-title":"Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial","volume":"187","author":"Kemper","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0037","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1086\/516512","article-title":"Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men","volume":"176","author":"Neilsen","year":"1997","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.amjmed.2018.12.011_bib0038","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/01.aids.0000186815.99993.55","article-title":"Response to hepatitis A vaccine in HIV patients in the HAART era","volume":"19","author":"Rimland","year":"2005","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2893.2005.00658.x","article-title":"Response to hepatitis A vaccine in HIV-positive patients","volume":"13","author":"Weissman","year":"2006","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-200001070-00002","article-title":"Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group","volume":"14","author":"Valdez","year":"2000","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0041","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2893.2006.00822.x","article-title":"Predictors of immunity after hepatitis A vaccination in HIV-infected persons","volume":"14","author":"Overton","year":"2007","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0042","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/QAI.0b013e31821fdec3","article-title":"Long-term persistence of humoral immunity after hepatitis A vaccination in HIV-infected adults","volume":"57","author":"Kern\u00e9is","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0043","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1086\/593335","article-title":"Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults","volume":"198","author":"Hammitt","year":"2008","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0044","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e318183a9c0","article-title":"Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study","volume":"49","author":"Launay","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9349","key":"10.1016\/j.amjmed.2018.12.011_bib0045","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.amjmed.2018.12.011_bib0046","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.amjmed.2018.12.011_bib0047","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/433180","article-title":"Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons","volume":"41","author":"Overton","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.amjmed.2018.12.011_bib0048","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0264-410X(99)00389-8","article-title":"Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load","volume":"18","author":"Rey","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0049","first-page":"67","article-title":"Management of hepatitis B virus in HIV-positive patients","volume":"52","author":"Shire","year":"2006","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0050","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.1989.00390060067014","article-title":"Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs","volume":"149","author":"Mannucci","year":"1989","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0051","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-109-2-101","article-title":"Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination","volume":"109","author":"Collier","year":"1988","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0052","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198607243150401","article-title":"Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men","volume":"315","author":"Hadler","year":"1986","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0053","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QAD.0b013e32832cd99e","article-title":"Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals","volume":"24","author":"Landrum","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.amjmed.2018.12.011_bib0054","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-3-9","article-title":"Randomized controlled trial of hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses","volume":"3","author":"Cornejo-Ju\u00e1rez","year":"2006","journal-title":"AIDS Res Ther"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/ijsa.2009.009126","article-title":"Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations","volume":"20","author":"Kim","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"10","key":"10.1016\/j.amjmed.2018.12.011_bib0056","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/420740","article-title":"Hepatitis A and B vaccination practices for ambulatory patients infected with HIV","volume":"38","author":"Tedaldi","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0057","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1360-0443.2002.00147.x","article-title":"Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response","volume":"97","author":"Quaglio","year":"2002","journal-title":"Addiction"},{"issue":"34","key":"10.1016\/j.amjmed.2018.12.011_bib0058","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2009.04.016","article-title":"Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count","volume":"27","author":"Landrum","year":"2009","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.amjmed.2018.12.011_bib0059","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.aids.0000183514.37513.d2","article-title":"CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults","volume":"19","author":"Cooper","year":"2005","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0060","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1086\/533467","article-title":"CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years","volume":"46","author":"Cooper","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0061","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1468-1293.2007.00473.x","article-title":"Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine","volume":"8","author":"Shafran","year":"2007","journal-title":"HIV Med"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0062","first-page":"2028","article-title":"Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response","volume":"89","author":"Jongjirawisan","year":"2006","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0063","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/524690","article-title":"A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients","volume":"197","author":"de Vries-Sluijs","year":"2008","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.amjmed.2018.12.011_bib0064","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jama.2011.351","article-title":"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial","volume":"305","author":"Launay","year":"2011","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.amjmed.2018.12.011_bib0065","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S1473-3099(15)00220-0","article-title":"Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial","volume":"15","author":"Rey","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0066","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hep.23886","article-title":"Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection","volume":"52","author":"El Chaar","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0067","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/jvh.12428","article-title":"T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients","volume":"22","author":"Wang","year":"2015","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0068","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/cid\/cis908","article-title":"Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study","volume":"56","author":"Witt","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0069","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/429302","article-title":"Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies","volume":"191","author":"Gandhi","year":"2005","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jinf.2012.03.009","article-title":"Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen","volume":"65","author":"Kaech","year":"2012","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0071","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/651422","article-title":"Serologic response to hepatitis B vaccination in HIV-infected patients with isolated positivity for antibodies to hepatitis B core antigen","volume":"50","author":"Chakvetadze","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.amjmed.2018.12.011_bib0072","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2893.2011.01482.x","article-title":"High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants","volume":"18","author":"Launay","year":"2011","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0073","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","article-title":"Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men","volume":"177","author":"Palefsky","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0074","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/QAI.0b013e3181a97be5","article-title":"Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy","volume":"51","author":"Fife","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0075","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/656320","article-title":"Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men","volume":"202","author":"Wilkin","year":"2010","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0076","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/cid\/cit319","article-title":"Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women","volume":"57","author":"Kahn","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0077","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1378\/chest.98.1.33","article-title":"Influenza in patients with human immunodeficiency virus infection","volume":"98","author":"Safrin","year":"1990","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0078","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/320747","article-title":"Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City","volume":"32","author":"Fine","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0079","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archinte.161.3.441","article-title":"Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome","volume":"161","author":"Lin","year":"2001","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0080","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/jmv.20684","article-title":"An outbreak of influenza in a residential drug-rehabilitation community","volume":"78","author":"Boschini","year":"2006","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0081","doi-asserted-by":"crossref","first-page":"e20111","DOI":"10.1371\/journal.pone.0020111","article-title":"Risk factors for hospitalized seasonal influenza in rural western Kenya","volume":"6","author":"Ope","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0082","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1017\/S0950268810002669","article-title":"Pneumonia and influenza hospitalization in HIV-positive seniors","volume":"139","author":"Mor","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.amjmed.2018.12.011_bib0083","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3201\/eid1911.130546","article-title":"Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011","volume":"19","author":"Cohen","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0084","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3201\/eid2104.141033","article-title":"Deaths associated with respiratory syncytial and influenza viruses among persons \u22655 years of age in HIV-prevalent area, South Africa, 1998-2009(1)","volume":"21","author":"Tempia","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118884","article-title":"Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013","volume":"10","author":"Cohen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.amjmed.2018.12.011_bib0086","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/cid\/ciq110","article-title":"Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature","volume":"52","author":"Sheth","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0087","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11904-011-0086-4","article-title":"Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic","volume":"8","author":"Sheth","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"43","key":"10.1016\/j.amjmed.2018.12.011_bib0088","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1016\/j.vaccine.2014.07.101","article-title":"Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety","volume":"32","author":"Remschmidt","year":"2014","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.amjmed.2018.12.011_bib0089","doi-asserted-by":"crossref","first-page":"F217","DOI":"10.1097\/00002030-199817000-00002","article-title":"Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy","volume":"12","author":"Kroon","year":"1998","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0090","doi-asserted-by":"crossref","first-page":"e17758","DOI":"10.1371\/journal.pone.0017758","article-title":"Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults","volume":"6","author":"Cooper","year":"2011","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.amjmed.2018.12.011_bib0091","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/S0264-410X(00)00079-7","article-title":"Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study","volume":"18","author":"Kroon","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0092","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/jama.1989.03430060075029","article-title":"The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine","volume":"262","author":"Miotti","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0093","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-158-1-201301010-00005","article-title":"Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial","volume":"158","author":"McKittrick","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0094","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e328359f27a","article-title":"Long-term immunogenicity of two doses of 2009 A\/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults","volume":"27","author":"Durier","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/cid\/ciq003","article-title":"Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients","volume":"52","author":"Bickel","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"49","key":"10.1016\/j.amjmed.2018.12.011_bib0096","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1016\/j.vaccine.2012.09.052","article-title":"Immune response after one or two doses of pandemic influenza A (H1N1) monovalent, AS03-adjuvanted vaccine in HIV infected adults","volume":"30","author":"Nielsen","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0097","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw226","article-title":"Meningococcal disease in patients with human immunodeficiency virus infection: a review of cases reported through active surveillance in the United States, 2000-2008","volume":"3","author":"Harris","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0098","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/0003-4819-160-1-201401070-00731","article-title":"Elevated risk for invasive meningococcal disease among persons with HIV","volume":"160","author":"Miller","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0099","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/INF.0b013e3181c38f3b","article-title":"Phase I\/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents","volume":"29","author":"Siberry","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpeds.2012.04.005","article-title":"Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus","volume":"161","author":"Lujan-Zilbermann","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0101","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1093\/jpids\/piw094","article-title":"Immunogenicity of a booster dose of quadrivalent meningococcal conjugate vaccine in previously immunized HIV-infected children and youth","volume":"6","author":"Warshaw","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"12","key":"10.1016\/j.amjmed.2018.12.011_bib0102","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1086\/430356","article-title":"Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000","volume":"191","author":"Heffernan","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QCO.0b013e328012c5f1","article-title":"HIV and pneumococcal disease","volume":"20","author":"Klugman","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0104","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7326\/0003-4819-117-4-314","article-title":"Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives","volume":"117","author":"Janoff","year":"1992","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0105","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1056\/NEJMoa0903029","article-title":"A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"362","author":"French","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0106","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/164.4.761","article-title":"Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex","volume":"164","author":"Glaser","year":"1991","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.amjmed.2018.12.011_bib0107","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0956462412472450","article-title":"Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147)","volume":"24","author":"Slayter","year":"2013","journal-title":"Int J STD AIDS"},{"issue":"9221","key":"10.1016\/j.amjmed.2018.12.011_bib0108","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0109","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/00002030-200405210-00018","article-title":"23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort","volume":"18","author":"Watera","year":"2004","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0110","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/infdis\/172.5.1253","article-title":"Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine","volume":"172","author":"Mascart-Lemone","year":"1995","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.amjmed.2018.12.011_bib0111","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.vaccine.2005.12.021","article-title":"Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study","volume":"24","author":"Falc\u00f3","year":"2006","journal-title":"Vaccine"},{"issue":"7-8","key":"10.1016\/j.amjmed.2018.12.011_bib0112","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0264-410X(00)00232-2","article-title":"Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults","volume":"19","author":"Kroon","year":"2000","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.amjmed.2018.12.011_bib0113","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/infdis\/173.6.1347","article-title":"IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response","volume":"173","author":"Rodriguez-Barradas","year":"1996","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0114","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-199812150-00005","article-title":"Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV","volume":"19","author":"Talesnik","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1468-1293.2009.00744.x","article-title":"A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy","volume":"11","author":"Hung","year":"2010","journal-title":"HIV Med"},{"issue":"38","key":"10.1016\/j.amjmed.2018.12.011_bib0116","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1016\/j.vaccine.2008.06.093","article-title":"Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"issue":"3-4","key":"10.1016\/j.amjmed.2018.12.011_bib0117","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0264-410X(01)00347-4","article-title":"Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and\/or 23-valent polysaccharide vaccine among HIV-infected adults","volume":"20","author":"Feikin","year":"2001","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.amjmed.2018.12.011_bib0118","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e3282887e91","article-title":"Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults","volume":"21","author":"Lesprit","year":"2007","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0119","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/QAD.0b013e3283389de5","article-title":"Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults","volume":"24","author":"Pe\u00f1aranda","year":"2010","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.amjmed.2018.12.011_bib0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/656147","article-title":"A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults","volume":"202","author":"Crum-Cianflone","year":"2010","journal-title":"J Infect Dis"},{"issue":"37","key":"10.1016\/j.amjmed.2018.12.011_bib0121","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2013.04.065","article-title":"Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil","volume":"31","author":"Ho","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0122","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.vaccine.2014.01.009","volume":"32","author":"Lu","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0123","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jiu631","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults previously vaccinated with pneumococcal polysaccharide vaccine","volume":"212","author":"Glesby","year":"2015","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0124","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1086\/651418","article-title":"Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults","volume":"50","author":"Rabian","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/653112","article-title":"Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial","volume":"51","author":"S\u00f8gaard","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"40","key":"10.1016\/j.amjmed.2018.12.011_bib0126","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.amjmed.2018.12.011_bib0127","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/clinids\/21.5.1197","article-title":"Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus","volume":"21","author":"Kroon","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00002030-199404000-00008","article-title":"Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes","volume":"8","author":"Kroon","year":"1994","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0129","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1699-0463.1992.tb04003.x","article-title":"Immunity against diphtheria and tetanus in human immunodeficiency virus-infected Danish men born 1950-59","volume":"100","author":"Kurtzhals","year":"1992","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.amjmed.2018.12.011_bib0130","first-page":"724","article-title":"Safety and immunogenicity of multiple conventional immunizations administered during early HIV infection","volume":"4","author":"Rhoads","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"28","key":"10.1016\/j.amjmed.2018.12.011_bib0131","first-page":"603","article-title":"Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993","volume":"45","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.amjmed.2018.12.011_bib0132","first-page":"1013","article-title":"Response of human immunodeficiency virus-infected adults to measles-rubella vaccination","volume":"6","author":"Sprauer","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"50","key":"10.1016\/j.amjmed.2018.12.011_bib0133","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1016\/j.vaccine.2009.09.063","article-title":"Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART","volume":"27","author":"Belaunzar\u00e1n-Zamudio","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.amjmed.2018.12.011_bib0134","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/00002030-199211000-00013","article-title":"Prevalence of measles antibodies in adults with HIV infection: possible risk factors of measles seronegativity","volume":"6","author":"Kemper","year":"1992","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.amjmed.2018.12.011_bib0135","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0264-410X(94)90247-X","article-title":"Measles seroprevalence and vaccine response in HIV-infected adults","volume":"12","author":"Wallace","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.amjmed.2018.12.011_bib0136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2013.10.027","article-title":"Disseminated vaccine-strain varicella as initial presentation of the acquired immunodeficiency syndrome: a case report and review of the literature","volume":"59","author":"Maves","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.amjmed.2018.12.011_bib0137","series-title":"Online Expert Poster Review and Discussion presented at the 19th Conference for Retroviruses and Opportunistic Infections (CROI)","article-title":"Zostavax is generally safe and immunogenic in HIV+ adults virologically suppressed on ART: results of a phase 2, randomized, double-blind, placebo-controlled trial","author":"Benson","year":"2012"},{"issue":"4","key":"10.1016\/j.amjmed.2018.12.011_bib0138","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4161\/hv.6.4.10654","article-title":"Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults","volume":"6","author":"Weinberg","year":"2010","journal-title":"Hum Vaccin"},{"issue":"8","key":"10.1016\/j.amjmed.2018.12.011_bib0139","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319300063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319300063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:17:21Z","timestamp":1757582241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319300063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0002934319300063"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.12.011","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}